"/> Novus Biologicals™ Peptide bloquant d’anticorps LG… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps LGI2

Réf. : BL-RE-054919Réf. fabricant : 18206888 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
55203
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76886. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 10 amino acids near the center of human LGI2.

Points forts

Source

Synthetic

(Accession #: Q8N0V4) The LGI2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-054919
Réf. fabricant18206888
Gene ID (Entrez)55203
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76886. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneFLJ10675, glioma inactivated 2, KIAA1916MGC126810, leucine-rich repeat LGI family, member 2, LGI1-like protein 2, MGC126808
Symbole de gène(s)LGI2
Type de produitLGI2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne10 amino acids near the center of human LGI2
Une question, une configuration particulière ?
Contactez-nous pour un devis.